Prof. Andrea Crisanti
Professor of Molecular Parasitology at the Imperial College London
Co-principal Investigator of INFRAVEC2
Andrea Crisanti’s group uses gene-editing technologies to develop strategies to eradicate the infectious malaria parasite in developing countries in Africa, Asia Pacific and the Amazon basin. Recently, his laboratory has demonstrated how CRISPR-Cas9 can be programmed to target genes in malaria-spreading mosquitoes, thereby impairing their sexual development and dramatically reduce their population.